Related Experiment Video
Updated: Oct 7, 2025

Monitoring Protein-RNA Interaction Dynamics In Vivo at High Temporal Resolution Using χCRAC
Published on: May 9, 2020
RNA-Binding Profiles of CKAP4 as an RNA-Binding Protein in Myocardial Tissues
Hong Zhu1,2, Yanfeng Zhang1,2, Chengliang Zhang1,2
1Department of Cardiovascular Surgery, Xiangya Hospital, Central South University, Changsha, China.
Insights
This study reveals CKAP4, a protein marker, binds to non-coding RNAs, including lncRNAs, and plays a role in cardiac fibrosis. CKAP4
Area of Science:
- Cardiovascular Biology
- Molecular Biology
- Epigenetics
Background:
- Pathological tissue remodeling, such as fibrosis, is a hallmark of various cardiac diseases.
- CKAP4, a marker for activated cardiac myofibroblasts, is implicated in cardiac remodeling, but its mechanisms remain unexplored.
Purpose of the Study:
- To investigate the role of CKAP4 in cardiac fibrotic remodeling as an RNA-binding protein.
- To identify and characterize RNAs bound by CKAP4 in normal and fibrotic atrial muscle.
Main Methods:
- Improved RNA immunoprecipitation and sequencing (iRIP-seq) to analyze CKAP4-bound RNAs.
- Quantitative PCR and Western blotting to assess CKAP4 expression.
- Bioinformatic analysis of binding peaks and motifs.
Main Results:
- CKAP4 preferentially binds to non-coding RNAs, particularly lncRNAs, in cardiac tissues.
- Differential binding of lncRNAs like LINC00504 and FLJ22447 was observed in remodeling myocardial tissues.
- CKAP4 expression is downregulated in human fibrotic atria, suggesting a protective role.
Conclusions:
- CKAP4 exhibits unconventional RNA-binding properties, suggesting a role in cardiac remodeling.
- Further research into CKAP4's structure and function can elucidate cardiac remodeling pathways.
- CKAP4 may represent a potential therapeutic target for cardiac fibrosis.
Abstract:
Background: Pathological tissue remodeling such as fibrosis is developed in various cardiac diseases. As one of cardiac activated-myofibroblast protein markers, CKAP4 may be involved in this process and the mechanisms have not been explored. Methods: We assumed that CKAP4 held a role in the regulation of cardiac fibrotic remodeling as an RNA-binding protein. Using improved RNA immunoprecipitation and sequencing (iRIP-seq), we sought to analyze the RNAs bound by CKAP4 in normal atrial muscle (IP1 group) and remodeling fibrotic atrial muscle (IP2 group) from patients with cardiac valvular disease. Quantitative PCR and Western blotting were applied to identify CKAP4 mRNA and protein expression levels in human right atrium samples. Results: iRIP-seq was successfully performed, CKAP4-bound RNAs were characterized. By statistically analyzing the distribution of binding peaks in various regions on the reference human genome, we found that the reads of IP samples were mainly distributed in the intergenic and intron regions implying that CKAP4 is more inclined to combine non-coding RNAs. There were 913 overlapping binding peaks between the IP1 and IP2 groups. The top five binding motifs were obtained by HOMER, in which GGGAU was the binding sequence that appeared simultaneously in both IP groups. Binding peak-related gene cluster enrichment analysis demonstrated these genes were mainly involved in biological processes such as signal transduction, protein phosphorylation, axonal guidance, and cell connection. The signal pathways ranking most varied in the IP2 group compared to the IP1 group were relating to mitotic cell cycle, protein ubiquitination and nerve growth factor receptors. More impressively, peak analysis revealed the lncRNA-binding features of CKAP4 in both IP groups. Furthermore, qPCR verified CKAP4 differentially bound lncRNAs including LINC00504, FLJ22447, RP11-326N17.2, and HELLPAR in remodeling myocardial tissues when compared with normal myocardial tissues. Finally, the expression of CKAP4 is down-regulated in human remodeling fibrotic atrium. Conclusions: We reveal certain RNA-binding features of CKAP4 suggesting a relevant role as an unconventional RNA-binding protein in cardiac remodeling process. Deeper structural and functional analysis will be helpful to enrich the regulatory network of cardiac remodeling and to identify potential therapeutic targets.
Related Concept Videos
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
Blood Studies for Cardiovascular System I: Cardiac Biomarkers
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...

